Malaysia

Is CBD Legal in Malaysia?

Status

Illegal

Covers

CBD

Jurisdiction

Independent Country

Last updated

May 29, 2026

The short answer

CBD is illegal in Malaysia for general sale. The Dangerous Drugs Act 1952 and the Poisons Act 1952 treat cannabidiol as a Group C poison and a controlled substance, with no distinction between hemp-derived and marijuana-derived extracts.

The Drug Control Authority (DCA), under the Ministry of Health, has not registered any over-the-counter CBD product. Epidyolex and similar cannabinoid medicines may be imported only through the special access scheme administered by the National Pharmaceutical Regulatory Agency (NPRA), case by case, on the application of a registered specialist. Personal import of CBD oils, gummies, vapes, and cosmetics is not permitted, and customs at KLIA routinely seizes shipments declared as CBD. Penalties for possession track those for cannabis under the Dangerous Drugs Act, exposing users to fines up to RM 20,000 and prison terms up to five years.

Wellness brands marketed online from Thailand or Singapore do not benefit from any cross-border exemption. Visible storefront sale of CBD does not exist in Malaysia.

This page is for informational purposes only and does not constitute legal advice. Verify current law with qualified counsel before making compliance decisions.

Key facts ·

Malaysia

Key facts

Rules at a glance

All countries

THC limit

Zero tolerance

Regulator

Drug Control Authority (DCA); National Pharmaceutical Regulatory Agency (NPRA); Ministry of Health

Key regulation

Dangerous Drugs Act 1952; Poisons Act 1952; Sale of Drugs Act 1952

Effective

April 14, 1952

Adult-use cannabis

Illegal

Medical cannabis

Limited

For brands and importers

Import and export rules

CBD imports require NPRA special access approval for individual named patients. Commercial CBD imports are not authorized. Customs seizes consumer shipments and refers cases for prosecution under the Dangerous Drugs Act.

FAQ

Common questions

Latest

Latest news and analysis

All news
No items found.